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Abstract
We have introduced a consistent nomenclature for the various subunits of the NatA-NatE N-
terminal acetyltransferases from yeast, humans and other eukaryotes.
Introduction
N-terminal acetylation has been extensively studied in
yeast and humans and represents one of the most com-
mon protein modifications in eukaryotes, occurring on
approximately 57% of yeast proteins and 84% human
proteins [1], although it is rare in prokaryotes. Eukaryotic
proteins initiate with methionine residues, which are
cleaved from nascent chains if the penultimate residue has
a radius of gyration of 1.29 Å or less [2]. N-terminal
acetylation subsequently occurs on certain of the proteins,
either containing or lacking the methionine residue, as
depicted in Fig. 1. The salient features of N-terminal
acetylation are summarized in Table 1 and Fig. 2. Detailed
reviews on the N-terminal acetyltransferases have
appeared [3-7], and the N-terminal acetylation status of
742 human and 616 yeast protein N-termini have been
compiled [1]. The wide range and diversity of substrates is
due in part to the large number of different N-terminal
acetylating enzymes, NatA-NatE. The sequence require-
ments for N-terminal acetylation vary with the N-terminal
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A summary of the major pathways of N-terminal processing  in eukaryotes, showing the four different termini Figure 1
A summary of the major pathways of N-terminal 
processing in eukaryotes, showing the four different 
termini. 1: Uncleaved and unacetylated Met-Xxx- N-ter-
mini; 2: Cleaved and unacetylated Xxx-N-termini; 3: 
Uncleaved and NatB/NatC acetylated Ac-Met-Xxx- N-ter-
mini; 4: Cleaved and NatA acetylated Ac-Xxx-N-termini. See 
Table 1 and Figure 2 for more detail.
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acetyltransferase. Only two amino acid residues, Met-Asn-,
Met-Asp-, or Met-Glu-, are required for at least partial N-
terminal acetylation by NatB [1,8]. On the other hand, 30
to 50 specific amino acids are required for N-terminal
acetylation by NatD [9]. Each of the three major N-termi-
nal acetyltransferases, NatA, NatB and NatC, contain a cat-
alytic subunit, and one or two auxiliary subunits (Table 1).
The sequence and functions of the yeast and human
orthologous subunits are obviously related. A yeast ard1-
nat1- strain was phenotypically complemented by
hARD1 hNAT1, suggesting that yNatA and hNatA are sim-
ilar. However, heterologous combinations, hARD1 yNAT1
and yARD1 hNAT1, were not functional in yeast, suggest-
ing significant structural subunit differences between the
species [1].
Nomenclature
During a recent international meeting on N-terminal
acetylation, it was pointed out that there is critical need to
revise the gene symbols encoding the N-terminal acetyl-
transferases. The main reason for changing the nomencla-
ture is so that each of the orthologous genes from different
species would have the same name. Furthermore, orthol-
ogous genes were assigned not only by similarity of their
sequences, but also by their action on the same set of pro-
teins. Yeast NatA and human NatA were shown to
acetylate the same set proteins by comparing a normal
yeast strain with the mutant naa10-  naa15-hNAA10
hNAA15 [1].
Table 1: Revised nomenclature for N-terminal acetyltransferases
Type NatA NatB NatC NatD NatE
Original
Catalytic subunit Ard1p Nat3p Mak3p Nat4p Nat5p
Auxiliary subunit Nat1p Mdm20p Mak10p †
Mak31p
Revised
Catalytic subunit Naa10p Naa20p Naa30p Naa40p Naa50p
Auxiliary subunit Naa15p Naa25p Naa35p †
Naa38p
Number of yeast substrates ~2,000 ~1,000 ~250 2? ?
Substrates* Ser- Met-Glu- Met-Ile- Ser-Gly-etc-?
Ala- Met-Asp- Met-Leu-
Gly- Met-Asn- Met-Trp-
Thr- Met-Phe-
Val-‡
Cys-¶
------------2 to 8 amino acids----------- 30–50 a. a ?
Naa50p is inferred to be an N-terminal acetyltransferase because of its sequence homology to known NATs.
* Acetylation occurs at least partially on all proteins with Met-Glu-, Met-Asp- and Met-Asn- termini, but only on subclasses of proteins with the other termini.
† Naa15p may be an auxiliary subunit of NatE, as well as an auxiliary subunit of NatA.
‡ Found in humans but not yeast (see Figure 2 legend).
¶One example found in yeast (see Figure 2 legend).
The major pathways of N-terminal processing in eukaryotes Figure 2
The major pathways of N-terminal processing in 
eukaryotes. Two methionine aminopeptidases (MAP), 
Map1p and Map2p, cleave N-terminal methionine residues 
that have small side chains (glycine, alanine, serine, cysteine, 
threonine, proline, and valine), although methionine is 
retained on some proteins having penultimate residues of 
valine. Subsequently, NatA, NatB, and NatC acetylate specific 
sequences as shown in the figure and in Table 1. Acetylation 
occurs at least partially on all proteins with Met-Glu-, Met-
Asp- and Met-Asn- termini, but only on subclasses of pro-
teins with the other termini. For example, acetylation occurs 
at least partially on 43% of proteins in yeast and on 96% of 
proteins in humans with Ala- termini. In addition, Ac-Cys-, 
Ac-Val-, Ac-Met-Met-, and Ac-Met-Lys- termini occurs on 
some proteins from humans but not from yeast; it is 
unknown which NATs are responsible for Ac-Cys-, Ac-Met-
Met-, and Ac-Met-Lys- acetylations.
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The use of the different symbols NAT, ARD, MDM, and
MAK is confusing, and does not provide useful informa-
tion, especially when applied to human NATs. We believe
it can be misleading to assign a gene symbol based on one
phenotype of a mutant when a large number of proteins
are affected, and when the mutant is pleiotropic.
Most importantly, different orthologous genes should
have different names. The symbols NAT1,  NAT2  and
NAT3 denote human genes encoding arylamine N-acetyl-
transferases, which are distinct from N-terminal acetyl-
transferases [10]. On the other hand, NCBI has designated
the human homologue of the yeast NAT genes as follows:
yNAT1  designated as hNARG1; yNAT3  designated as
hNAT5; and yNAT5 designated as hNAT13. Also, ARD1 is
used to describe the ADP-ribosylation factor domain pro-
tein 1 [11].
Therefore, in this paper we have introduced a new nomen-
clature for protein N-terminal acetyltransferases in
eukaryotes (Table 1). It is important to note that NAA (N
acetyltransferases) is not used to designate any other gene
in yeast or higher eukaryotes. We have assigned each of
the subunits of the NatA-NatE complexes a Naa symbol,
as presented in Table 1. We have also recommended a
nomenclature for paralogs of human NatA complexes 
containing either Naa10p or Naa11p in combination with
either Naa15p or Naa16p (Table 2). The revised symbols,
along with synonyms from yeast and humans, are pre-
sented in Table 3. Clearly, this revised nomenclature will
greatly diminish the confusion in describing orthologous
subunits from different species.
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